Autologous Stem Cell Transplantation for Crohn's Disease
Recruiting now · Phase 1/Phase 2
Conditions studied: Crohn's Disease
In brief
The objective of this study is to evaluate the safety and effectiveness of administering high-dose chemotherapy followed by infusion of autologous CD34-selected peripheral blood stem cells (PBSC) in pediatric and adult patients with severe Crohn's disease.
Key facts
- Study ID
- NCT00692939
- Run by
- Paul Szabolcs
- People needed
- 20
- Starts
- 2012-06-26
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2025-12-15
Who can join
Age: 10 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UPMC Prebyterian- Adult Gastroenterology — Pittsburgh, Pennsylvania, United States (enrolling)
- Children's Hospital of Pittsburgh of UPMC-Bone Marrow Team — Pittsburgh, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.